-
Entity
-
Individual
-
Location
-
C/O Idenix Pharmaceuticals, Inc., One Kendall Square, Bldg. 1400, Cambridge, MA
-
Summary
-
The estimated net worth of Daniella Beckman is at least $1.68M dollars as of February 6, 2025. Daniella Beckman is the Director of Blueprint Medicines Corp and owns shares of Blueprint Medicines Corp (BPMC) stock worth about $1.21M. Daniella Beckman is the Chief Financial Officer of Tango Therapeutics, Inc. and owns shares of Tango Therapeutics, Inc. (TNGX) stock worth about $475K.